US2020046981A1PendingUtilityA1
Selective stimulation to modulate the sympathetic nervous system
Assignee: UNIV LELAND STANFORD JUNIORPriority: Sep 8, 2004Filed: Mar 18, 2019Published: Feb 13, 2020
Est. expirySep 8, 2024(expired)· nominal 20-yr term from priority
A61N 1/0551A61N 1/36071A61N 1/36057A61N 1/36135A61N 1/36114
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Systems, methods and devices are provided for the targeted treatment of a variety of medical conditions by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies. Typically, the target anatomy includes one or more dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions thereof. Such target stimulation areas are utilized due in part to their effect on the sympathetic nervous system.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating an eating disorder in a patient, comprising:
implanting a first stimulation lead with at least one electrode positioned to selectively stimulate a dorsal root ganglion (DRG) in the patient; implanting a second stimulation lead with at least one electrode positioned to stimulate neural tissue of a sympathetic chain of the patient that is downstream from the DRG; and applying electrical stimulation, from at least one implantable pulse generator and using the first and second stimulation leads, to the DRG and to the neural tissue of the sympathetic chain to selectively modulate gastric motility and hunger in the patient and to modulate hormonal regulation to treat the eating disorder of the patient.Join the waitlist — get patent alerts
Track US2020046981A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.